ask="12.25"
ask_size="500"
average_daily_volume="1823140"
bid="9.12"
bid_size="200"
book_value="-0.09"
change="-0.03"
change_from_200_day_moving_average="0.87"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-2.34"
change_From_52_week_low="4.52"
change_in_percent="-0.25%"
close="12.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94803000"
high="12.30"
high_52_weeks="14.38"
last_trade_date="2/23/2017"
last_trade_price="12.04"
last_trade_size="41794"
last_trade_time="4:00pm"
low="11.71"
low_52_weeks="7.52"
market_capitalization="1.54B"
moving_average_200_day="11.17"
moving_average_50_day="12.10"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.12"
pe_ratio="N/A"
peg_ratio="-0.26"
percent_change_from_200_day_moving_average="+7.77%"
percent_change_from_50_day_moving_average="-0.50%"
percent_change_from_52_week_high="-16.27%"
percent_change_from_52_week_low="+60.11%"
previous_close="12.07"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.67"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="HALO"
volume="1106731"
weeks_range_52="7.52 - 14.38"
